Kraig Biocraft Laboratories annual ebitda
2011
2012
2013
2014
2015
2016
2017
2018
Kraig Biocraft Laboratories EBITDA Growth & History (KBLB)
Kraig Biocraft Laboratories's calculated EBITDA was −$933,315 for fiscal 2018.
View full Kraig Biocraft Laboratories company overviewKraig Biocraft Laboratories annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2018 | 2018-12-31 | −$933,315 | $1.2M | — |
| 2017 | 2017-12-31 | −$2.1M | $792,926 | — |
| 2016 | 2016-12-31 | −$2.9M | −$889,510 | — |
| 2015 | 2015-12-31 | −$2.0M | −$211,921 | — |
| 2014 | 2014-12-31 | −$1.8M | $381,777 | — |
| 2013 | 2013-12-31 | −$2.2M | −$654,153 | — |
| 2012 | 2012-12-31 | −$1.6M | −$262,783 | — |
| 2011 | 2011-12-31 | −$1.3M | — | — |
Kraig Biocraft Laboratories quarterly ebitda
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2019 | 2019-09-30 | −$1.0M | −$906,634 | — |
| Q2 2019 | 2019-06-30 | −$328,505 | −$182,218 | — |
| Q1 2019 | 2019-03-31 | −$405,345 | −$185,183 | — |
| Q4 2018 | 2018-12-31 | −$425,692 | −$180,896 | — |
| Q3 2018 | 2018-09-30 | −$141,174 | $87,841 | — |
| Q2 2018 | 2018-06-30 | −$146,287 | $1.1M | — |
| Q1 2018 | 2018-03-31 | −$220,162 | $230,027 | — |
| Q4 2017 | 2017-12-31 | −$244,796 | $628,698 | — |
| Q3 2017 | 2017-09-30 | −$229,015 | $855,846 | — |
| Q2 2017 | 2017-06-30 | −$1.2M | −$715,184 | — |
| Q1 2017 | 2017-03-31 | −$450,189 | $23,566 | — |
| Q4 2016 | 2016-12-31 | −$873,494 | −$493,434 | — |
| Q3 2016 | 2016-09-30 | −$1.1M | −$766,299 | — |
| Q2 2016 | 2016-06-30 | −$496,520 | $442,648 | — |
| Q1 2016 | 2016-03-31 | −$473,755 | −$72,425 | — |
| Q4 2015 | 2015-12-31 | −$380,060 | $41,728 | — |
| Q3 2015 | 2015-09-30 | −$318,562 | −$108,129 | — |
| Q2 2015 | 2015-06-30 | −$939,168 | −$395,028 | — |
| Q1 2015 | 2015-03-31 | −$401,330 | $249,508 | — |
| Q4 2014 | 2014-12-31 | −$421,788 | $306,331 | — |
| Q3 2014 | 2014-09-30 | −$210,433 | $728,911 | — |
| Q2 2014 | 2014-06-30 | −$544,140 | −$259,933 | — |
| Q1 2014 | 2014-03-31 | −$650,838 | −$393,532 | — |
| Q4 2013 | 2013-12-31 | −$728,119 | −$85,958 | — |
| Q3 2013 | 2013-09-30 | −$939,344 | −$663,820 | — |
| Q2 2013 | 2013-06-30 | −$284,207 | $216,242 | — |
| Q1 2013 | 2013-03-31 | −$257,306 | −$120,617 | — |
| Q4 2012 | 2012-12-31 | −$642,161 | −$315,693 | — |
| Q3 2012 | 2012-09-30 | −$275,524 | — | — |
| Q2 2012 | 2012-06-30 | −$500,449 | — | — |
| Q1 2012 | 2012-03-31 | −$136,689 | — | — |
| Q3 2011 | 2011-09-30 | −$326,468 | — | — |
Kraig Biocraft Laboratories ebitda trends
Over the last five reported fiscal years, Kraig Biocraft Laboratories's ebitda increased from −$2.2M to −$933,315, a change of $1.3M. The latest reported quarter, Q3 2019, shows −$1.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kraig Biocraft Laboratories filings at SEC.gov ↗